Thought Leadership Archives

Digital GI Health – Sam Holliday, CEO, Oshi Health – Part 1 of 2
On post-COVID telehealth, digital healthcare, virtual-first primary and specialty care, and building the future of GI care

First 2021 post in our series of B2B thought leadership interviews with visionary digital health entrepreneurs working to improve care of chronic conditions. In keeping with our mission, we particularly care about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. Bonnie and Ellen were happy to finally interview digital

Post-Viral Syndromes – A History of Neglect (Long COVID Part 2)
The emergence of post-Covid syndrome shines new light on post-viral syndromes

The emergence of post-COVID syndrome shines new light on the old problem of post-viral syndromes In Part 1, we discussed how the rise of long covid shines new light on chronic post-viral disorders long ignored by researchers and clinicians. But this issue didn’t just appear with the SARS-COV-2 COVID-19 pandemic.

Will Long COVID Change the Game for Autoimmune Diseases, too? Part 1

Will long-COVID activists, especially practitioner-patients, finally force healthcare systems, clinicians and medical researchers to confront post-viral and similar chronic syndromes they have shrugged off for decades? In keeping with our mission, will a focused response by healthcare systems and researchers to post-COVID syndrome help illuminate the invisible epidemic of autoimmune and autoinflammatory disorders?

Chase Spurlock, PhD, Founder & CEO of Decode Health, on Predictive Data Analytics for COVID-19 & Chronic Disease*

Dr Bonnie 360 interviews Chase Spurlock, PhD, founder and CEO of Decode Health on AI analytics in COVID and chronic inflammatory disease.

The State of Autoimmunity 2016 — A Progress Report: Part 2 (re-posted from Tincture)

In Part 2 of The State of Autoimmunity 2016, we will examine how established and emerging companies are utilizing advances in technology. More importantly, we describe how these companies and chronic disease management platforms can help create individualized autoimmune care. In Part 1, we discussed autoimmune disease as an untapped

Digital Health & Chronic Disease Care Post COVID (Part 2)

The COVID-19 pandemic and healthcare systems’ responses to it have been the biggest disruptors in digital health’s 30-year history. We hope this will be the biggest disruptor for a few decades to come! Therefore, this is a unique moment of opportunity for digital health. Especially for digital and virtual-first chronic

Digital Health & Chronic Disease Care Post-COVID (Part 1)

The COVID-19 pandemic and response is transforming healthcare in many ways, with unpredictable consequences. In fact, the pandemic and healthcare systems’ responses to it are the biggest disruptors in 30 years of digital health. Hopefully, this will be the biggest disruptor for a few decades to come! We see the

Dr Kosinski, MD, MBA, SonarMD Founder

On GI practice, beta risk, digital health, VBP and chronic care Another in our new series of B2B thought leadership interviews with visionary entrepreneurs applying digital tools to improve care of chronic immunoinflammatory disorders (CID), including autoimmune and autoinflammatory diseases. We were delighted to speak with Dr Lawrence R. Kosinski,

The State of Autoimmunity 2016 — A Progress Report: Part 1 (re-posted from Tincture)

Applying Technology to Empower Patients. 2016’s trends gave us glimmers of towards crossing the autoimmune abyss and achieving the vision of individualized autoimmune care. What was the state of autoimmunity in 2016, that unforgettable year full of positive and negative events? One positive development was increasing awareness of the unmet

Bill Conlan & CrossBridge (Part 2)

See Part 1 for how Bonnie met Bill Conlan pre-CrossBridge and for background on his entrepreneurial track record. That background includes SaaS platforms, analytics and the migration from fee-for-service (FFS) to value-based payments (VBP). Part 1 also lays out the challenges Bill saw for specialty practices in chronic disease management.